Topics

CTC Detection Linked to Relapse in Stage III Melanoma

11:03 EST 12 Feb 2020 | OncLive

The presence of circulating tumor cell was found to be independently associated with relapse in patients with stage III melanoma, suggesting that CTC assessment may be useful in identify patients who are at risk for relapse and could benefit from adjuvant therapy.

Original Article: CTC Detection Linked to Relapse in Stage III Melanoma

NEXT ARTICLE

More From BioPortfolio on "CTC Detection Linked to Relapse in Stage III Melanoma"

Quick Search

Relevant Topic

Melanoma
Melanoma is a highly malignant tumor of melanin-forming cells (melanocytes) There are most commonly found in the skin (resulting from sunlight exposure), but also in the eyes and mucous membranes. Metastasis to other regions of the body is also common....